{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:37:19Z","timestamp":1762421839085,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"vor","delay-in-days":675,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Particle Therapy"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.14338\/ijpt-21-00010","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T09:44:45Z","timestamp":1634636685000},"page":"76-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pericardial Effusion during Proton Therapy in a Patient with Chemorefractory Hodgkin Lymphoma"],"prefix":"10.1016","volume":"8","author":[{"given":"Ashley","family":"Way","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savas","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Berges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nataliya","family":"Getman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoying","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy P.","family":"Mendenhall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham Collins","family":"MA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Cutter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond B.","family":"Mailhot Vega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.14338\/IJPT-21-00010_i2331-5180-8-4-76-b01","series-title":"StatPearls [Internet]","article-title":"Hodgkin Lymphoma","author":"Kaseb","year":"2021"},{"key":"10.14338\/IJPT-21-00010_i2331-5180-8-4-76-b02","first-page":"116","article-title":"Hodgkin lymphoma: a review and update on recent progress","volume":"68","author":"Shanbhag","year":"2018","journal-title":"CA Cancer J Clin"},{"year":"1975","series-title":"SEER cancer statistics review","key":"10.14338\/IJPT-21-00010_i2331-5180-8-4-76-b03"},{"key":"10.14338\/IJPT-21-00010_i2331-5180-8-4-76-b04","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/485071","article-title":"The role of radiotherapy in Hodgkin's lymphoma: what has been achieved during the last 50 years?","volume":"2015","author":"Witkowska","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.14338\/IJPT-21-00010_i2331-5180-8-4-76-b05","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/icvts\/ivs491","article-title":"Risk factors affecting the survival rate in patients with symptomatic pericardial effusion undergoing surgical intervention","volume":"16","author":"Mirhosseini","year":"2013","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.14338\/IJPT-21-00010_i2331-5180-8-4-76-b06","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1002\/1097-0142(197606)37:6<2813::AID-CNCR2820370637>3.0.CO;2-S","article-title":"Mantle irradiation in Hodgkin's disease. An analysis of technique, tumor eradication, and complications","volume":"37","author":"Carmel","year":"1976","journal-title":"Cancer"},{"key":"10.14338\/IJPT-21-00010_i2331-5180-8-4-76-b07","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/pbc.20993","article-title":"Pericardial involvement at diagnosis in pediatric Hodgkin lymphoma patients","volume":"49","author":"Bashir","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.14338\/IJPT-21-00010_i2331-5180-8-4-76-b08","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1007\/s00059-018-4769-0","article-title":"Clinical characteristics and prognosis of cardiac tamponade patients: 5 year experience at a tertiary center","volume":"45","author":"Kiziltunc","year":"2020","journal-title":"Herz"},{"key":"10.14338\/IJPT-21-00010_i2331-5180-8-4-76-b09","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1182\/blood-2018-02-834465","article-title":"Pericardial effusion in Hodgkin lymphoma: a report from the Children's Oncology Group AHOD0031 protocol","volume":"132","author":"Marks","year":"2018","journal-title":"Blood"},{"key":"10.14338\/IJPT-21-00010_i2331-5180-8-4-76-b10","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-78581-y","article-title":"The role of (18)F-fluorodeoxyglucose-positron emission tomography\/computed tomography in the differential diagnosis of pericardial disease","volume":"10","author":"Hyeon","year":"2020","journal-title":"Sci Rep"},{"key":"10.14338\/IJPT-21-00010_i2331-5180-8-4-76-b11","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jacc.2015.06.1332","article-title":"Outcomes of cancer patients undergoing percutaneous pericardiocentesis for pericardial effusion","volume":"66","author":"El Haddad","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.14338\/IJPT-21-00010_i2331-5180-8-4-76-b12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1056\/NEJM195501202520301","article-title":"Pleural effusion; a statistical study of 436 patients","volume":"252","author":"Leuallen","year":"1955","journal-title":"N Engl J Med"},{"key":"10.14338\/IJPT-21-00010_i2331-5180-8-4-76-b13","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0002-9343(81)90168-6","article-title":"Pericardial disease in patients with cancer. The differentiation of malignant from idiopathic and radiation-induced pericarditis","volume":"71","author":"Posner","year":"1981","journal-title":"Am J Med"},{"key":"10.14338\/IJPT-21-00010_i2331-5180-8-4-76-b14","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1200\/JCO.1999.17.5.1425","article-title":"Phase II trial of liposome-encapsulated doxorubicin, cyclophosphamide, and fluorouracil as first-line therapy in patients with metastatic breast cancer","volume":"17","author":"Valero","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.14338\/IJPT-21-00010_i2331-5180-8-4-76-b15","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1023\/A:1011196910325","volume":"12","author":"Dazzi","year":"2001","journal-title":"Ann Oncol"},{"key":"10.14338\/IJPT-21-00010_i2331-5180-8-4-76-b16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/jrr\/rry029","article-title":"Risk factors for pericardial effusion after chemoradiotherapy for thoracic esophageal cancer-comparison of four-field technique and traditional two opposed fields technique","volume":"59","author":"Takata","year":"2018","journal-title":"J Radiat Res"},{"key":"10.14338\/IJPT-21-00010_i2331-5180-8-4-76-b17","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1161\/CIRCULATIONAHA.117.030571","article-title":"Clinical features, management, and outcomes of immune checkpoint inhibitor-related cardiotoxicity","volume":"136","author":"Escudier","year":"2017","journal-title":"Circulation"}],"container-title":["International Journal of Particle Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2331518024000519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2331518024000519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/meridian.allenpress.com\/theijpt\/article-pdf\/8\/4\/76\/3030690\/i2331-5180-8-4-76.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/theijpt\/article-pdf\/8\/4\/76\/3030690\/i2331-5180-8-4-76.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:34:04Z","timestamp":1762421644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2331518024000519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2331518024000519"],"URL":"https:\/\/doi.org\/10.14338\/ijpt-21-00010","relation":{},"ISSN":["2331-5180"],"issn-type":[{"type":"print","value":"2331-5180"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pericardial Effusion during Proton Therapy in a Patient with Chemorefractory Hodgkin Lymphoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Particle Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14338\/IJPT-21-00010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 \u00a9 2022 THE AUTHORS. Published by Elsevier BV on behalf of the Particle Therapy Co-operative Group. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}